Abstract
Clonal analysis is important for many areas of hematopoietic stem cell research, including in vitro cell expansion, gene therapy, and cancer progression and treatment. A common approach to measure clonality of retrovirally transduced cells is to perform integration site analysis using Southern blotting or polymerase chain reaction-based methods. Although these methods are useful in principle, they generally provide a low-resolution, biased, and incomplete assessment of clonality. To overcome those limitations, we labeled retroviral vectors with random sequence tags or "barcodes." On integration, each vector introduces a unique, identifiable, and heritable mark into the host cell genome, allowing the clonal progeny of each cell to be tracked over time. By coupling the barcoding method to a sequencing-based detection system, we could identify major and minor clones in 2 distinct cell culture systems in vitro and in a long-term transplantation setting. In addition, we demonstrate how clonal analysis can be complemented with transgene expression and integration site analysis. This cellular barcoding tool permits a simple, sensitive assessment of clonality and holds great promise for future gene therapy protocols in humans, and any other applications when clonal tracking is important. (Blood. 2010;115(13):2610-2618)
Original language | English |
---|---|
Pages (from-to) | 2610-2618 |
Number of pages | 9 |
Journal | Blood |
Volume | 115 |
Issue number | 13 |
DOIs | |
Publication status | Published - 1-Apr-2010 |
Keywords
- SELF-RENEWAL CAPACITY
- STEM-CELLS
- IN-VIVO
- GENE-THERAPY
- DEFICIENT MICE
- TERM
- DIFFERENTIATION
- MOUSE
- QUANTIFICATION
- PRECURSORS